31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
Jonesboro Supermarket Refused to Accommodate Disabled Employee and Unlawfully Fired Him, Federal Age...
Read More >
Originally set to take effect on Jan. 1, 2020, the City of Philadelphia's Fair Workweek Law implemen...
Read More >
This week the General Assembly of North Carolina provided some relief to developers with active deve...
Read More >
Competition/antitrust laws generally require rival firms to operate on the market independently of e...
Read More >
Matthew Friedman is the CEO of The Mekong Club, an organization supporting the private sector in the...
Read More >
On December 17, 2019, the US House of Representatives approved an appropriations bill, which include...
Read More >